218 related articles for article (PubMed ID: 11586265)
1. Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells.
Lin MF; Lee MS; Zhou XW; Andressen JC; Meng TC; Johansson SL; West WW; Taylor RJ; Anderson JR; Lin FF
J Urol; 2001 Nov; 166(5):1943-50. PubMed ID: 11586265
[TBL] [Abstract][Full Text] [Related]
2. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
3. Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer.
Veeramani S; Yuan TC; Chen SJ; Lin FF; Petersen JE; Shaheduzzaman S; Srivastava S; MacDonald RG; Lin MF
Endocr Relat Cancer; 2005 Dec; 12(4):805-22. PubMed ID: 16322323
[TBL] [Abstract][Full Text] [Related]
4. Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells.
Meng TC; Lee MS; Lin MF
Oncogene; 2000 May; 19(22):2664-77. PubMed ID: 10851066
[TBL] [Abstract][Full Text] [Related]
5. Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells.
Lin MF; DaVolio J; Garcia-Arenas R
Cancer Res; 1992 Sep; 52(17):4600-7. PubMed ID: 1380886
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the expression of prostatic acid phosphatase in LNCaP human prostate carcinoma cells.
Lin MF; Garcia-Arenas R; Kawachi M; Lin FF
Cell Mol Biol Res; 1993; 39(8):739-50. PubMed ID: 7951413
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase.
Lin MF; Meng TC
Biochem Biophys Res Commun; 1996 Sep; 226(1):206-13. PubMed ID: 8806615
[TBL] [Abstract][Full Text] [Related]
8. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells.
Lee MS; Igawa T; Yuan TC; Zhang XQ; Lin FF; Lin MF
Oncogene; 2003 Feb; 22(5):781-96. PubMed ID: 12569372
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter.
Zelivianski S; Igawa T; Lim S; Taylor R; Lin MF
Oncogene; 2002 May; 21(23):3696-705. PubMed ID: 12032838
[TBL] [Abstract][Full Text] [Related]
10. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
11. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
Landry F; Chapdelaine A; Bégin LR; Chevalier S
J Urol; 1996 Jan; 155(1):386-90. PubMed ID: 7490893
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells.
Meng TC; Lin MF
J Biol Chem; 1998 Aug; 273(34):22096-104. PubMed ID: 9705354
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C pathway is involved in regulating the secretion of prostatic acid phosphatase in human prostate cancer cells.
Lin MF; Zhang XQ; Dean J; Lin FF
Cell Biol Int; 2001; 25(11):1139-48. PubMed ID: 11913958
[TBL] [Abstract][Full Text] [Related]
14. Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells.
Lin MF; Lee MS; Garcia-Arenas R; Lin FF
Cell Biol Int; 2000; 24(10):681-9. PubMed ID: 11023645
[TBL] [Abstract][Full Text] [Related]
15. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ
BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
[TBL] [Abstract][Full Text] [Related]
16. Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo.
Nagasawa J; Mizokami A; Koshida K; Yoshida S; Naito K; Namiki M
Int J Urol; 2006 May; 13(5):587-92. PubMed ID: 16771730
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a prostate-specific tyrosine phosphatase by mutagenesis and expression in human prostate cancer cells.
Zhang XQ; Lee MS; Zelivianski S; Lin MF
J Biol Chem; 2001 Jan; 276(4):2544-50. PubMed ID: 11067847
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase PTP1B is involved in neuroendocrine differentiation of prostate cancer.
Wu C; Zhang L; Bourne PA; Reeder JE; di Sant'Agnese PA; Yao JL; Na Y; Huang J
Prostate; 2006 Aug; 66(11):1125-35. PubMed ID: 16652382
[TBL] [Abstract][Full Text] [Related]
19. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC
Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027
[TBL] [Abstract][Full Text] [Related]
20. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
